Luo Y - Search Results

1

Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT.

Ye Y, Labopin M, Chen J, Wu D, Gedde-Dahl T Sr, Blaise D, Socie G, Forcade E, Salmenniemi U, Maury S, Versluis J, Bazarbachi A, Nagler A, Brissot E, Li L, Luo Y, Shi J, Ciceri F, Huang H, Mohty M, Gorin NC. Ye Y, et al. Among authors: luo y. Blood Cancer J. 2024 May 27;14(1):85. doi: 10.1038/s41408-024-01072-0. Blood Cancer J. 2024. PMID: 38802349 Free PMC article. No abstract available.

2

[Preparation and characterization of monoclonal antibody against human telomeric repeat binding factor 1].

Huang H, Shi J, Chen Q, Luo Y, Ding W, Lou J. Huang H, et al. Among authors: luo y. Zhonghua Xue Ye Xue Za Zhi. 2002 Dec;23(12):631-3. Zhonghua Xue Ye Xue Za Zhi. 2002. PMID: 12667345 Chinese.

3

[Telomerase activity of human bone marrow mesenchymal stem cells].

Li JY, La XY, Luo Y, Sun J, Yu J, Lan JP, Zhu YY, Tan YM, Lin MF, Huang H. Li JY, et al. Among authors: luo y. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2004 Nov;33(6):481-5. doi: 10.3785/j.issn.1008-9292.2004.06.003. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2004. PMID: 15586402 Chinese.

4

[Isolation of Tara protein and its gene cloning].

Lan JP, Luo Y, Zhu YY, Sun J, Lai XY, Li JY, Yu J, Shi JM, Lin MF, Huang H. Lan JP, et al. Among authors: luo y. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2004 Nov;33(6):486-90. doi: 10.3785/j.issn.1008-9292.2004.06.004. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2004. PMID: 15586403 Chinese.

5

[Tandem autotransplants of peripheral blood stem cells following sequential high-dose CHOEP chemotherapy for aggressive lymphoma].

Luo Y, Huang H, Cai Z, Li L, Xie WZ, Meng XJ, Lin MF. Luo Y, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Aug;13(4):628-30. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005. PMID: 16129048 Chinese.

6

Shi JM, Huang H, Cai Z, Luo Y, Ye XJ, Zhang J, Li L, He JS, Xie WZ, Zheng WY, Meng XJ, Lin MF. Shi JM, et al. Among authors: luo y. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2006 Mar;35(2):122-6. doi: 10.3785/j.issn.1008-9292.2006.02.002. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2006. PMID: 16610075 Chinese.

7

[Clinical observation of Gleevec combined with myeloablative allogeneic stem cells transplantation in treatment of chronic myeloid leukemia].

Luo Y, Pan J, Shi JM. Luo Y, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 Jul;36(4):343-7. doi: 10.3785/j.issn.1008-9292.2007.04.006. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007. PMID: 17717824 Chinese.

8

Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells.

Zhao YM, Li JY, Lan JP, Lai XY, Luo Y, Sun J, Yu J, Zhu YY, Zeng FF, Zhou Q, Huang H. Zhao YM, et al. Among authors: luo y. Biochem Biophys Res Commun. 2008 May 16;369(4):1114-9. doi: 10.1016/j.bbrc.2008.03.011. Epub 2008 Mar 11. Biochem Biophys Res Commun. 2008. PMID: 18339310

9

Is hepatitis B virus reactivation a risk factor in the development of posttransplant lymphoproliferative disorder following liver transplantation?

Luo Y, Zhang AB, Huang H, Zheng SS. Luo Y, et al. Chin Med J (Engl). 2008 Jul 5;121(13):1237-40. Chin Med J (Engl). 2008. PMID: 18710646 No abstract available.

10

Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese population.

Zhao Y, Liu L, Wang Y, Wu G, Lai X, Cao W, Luo Y, Tan Y, Shi J, Xie W, Ye X, Cai Z, Lin M, Huang H. Zhao Y, et al. Among authors: luo y. Int J Hematol. 2009 May;89(4):445-451. doi: 10.1007/s12185-009-0292-7. Epub 2009 Apr 7. Int J Hematol. 2009. PMID: 19350352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,903 results

Search Page

Filters